Back
Alpha Architect US Quantitative Momentum ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
52
QMOM
Alpha Architect US Quantitative Momentum ETF
Last Price:
$66.38
Seasonality Move:
8.28%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$36.08
Seasonality Move:
-22.7%
Buy
52
Alpha Architect US Quantitative Momentum ETF (QMOM)
is a Buy
Is Alpha Architect US Quantitative Momentum ETF a Buy, Sell or Hold?
-
The current Alpha Architect US Quantitative Momentum ETF [QMOM] share price is $66.72. The Score for QMOM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
QMOM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QMOM Stock Price Chart
What is Alpha Architect US Quantitative Momentum ETF's stock price today?
-
The Alpha Architect US Quantitative Momentum ETF share price today is $66.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QMOM is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $35.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
QMOM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.45 | Buy |
| Relative Strength Index (14 RSI): | 56.72 | Buy |
| Chaikin Money Flow: | 6956 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.59 - 66.59) | Buy |
| Bollinger Bands (100): | (62.96 - 65.9) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.23 | Buy |
| Relative Strength Index (14 RSI): | 66.16 | Buy |
| Chaikin Money Flow: | -92149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.48 - 34.66) | Buy |
| Bollinger Bands (100): | (10.81 - 25.25) | Buy |
QMOM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.84 | Buy |
| 20-day SMA: | 65.65 | Buy |
| 50-day SMA: | 65.18 | Buy |
| 200-day SMA: | 62.58 | Buy |
| 8-day EMA: | 51.59 | Buy |
| 20-day EMA: | 29.81 | Buy |
| 50-day EMA: | 14.07 | Buy |
| 200-day EMA: | 3.84 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 30.4 | Buy |
| 50-day SMA: | 22.87 | Buy |
| 200-day SMA: | 13.87 | Buy |
| 8-day EMA: | 35.03 | Buy |
| 20-day EMA: | 31.05 | Buy |
| 50-day EMA: | 24.98 | Buy |
| 200-day EMA: | 18 | Buy |
Alpha Architect US Quantitative Momentum ETF Earnings Growth & QMOM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Alpha Architect US Quantitative Momentum ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||